(NEXT50IETF) Icicipramc Icicinxt50 MACD charts technical analysis
(NEXT50IETF) Icicipramc Icicinxt50 MACD charts technical analysis MACD analysis of Icicipramc Icicinxt50 | Buy/Sell Icicipramc Icicinxt50
10 day averaged volume of Icicipramc Icicinxt50 is 1380278
Date | Closing Price | Open | High | Low | Volume |
29 Thu May 2025 | 70.07 | 69.99 | 71.15 | 69.86 | 0.638 Mn |
28 Wed May 2025 | 69.99 | 68.50 | 71.70 | 68.50 | 1.785 Mn |
27 Tue May 2025 | 70.26 | 68.25 | 70.60 | 68.25 | 1.563 Mn |
26 Mon May 2025 | 70.36 | 71.93 | 71.93 | 70.07 | 0.925 Mn |
23 Fri May 2025 | 70.05 | 67.62 | 70.49 | 67.62 | 0.476 Mn |
22 Thu May 2025 | 69.71 | 70.40 | 70.40 | 69.36 | 0.526 Mn |
21 Wed May 2025 | 69.92 | 69.44 | 69.99 | 68.96 | 0.929 Mn |
20 Tue May 2025 | 69.22 | 70.88 | 70.88 | 69.10 | 1.434 Mn |
19 Mon May 2025 | 70.29 | 71.38 | 71.38 | 68.03 | 0.967 Mn |
16 Fri May 2025 | 70.13 | 67.02 | 70.31 | 67.02 | 4.451 Mn |
Indicators analysis of Icicipramc Icicinxt50 (NEXT50IETF)
MACD generated a BUY signal for Icicipramc Icicinxt50 in short term and the buy signal is strong.
MACD charts
Price action analysis of Icicipramc Icicinxt50 ( (NEXT50IETF) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Icicipramc Icicinxt50 ( (NEXT50IETF) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Icicipramc Icicinxt50 ( (NEXT50IETF) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Icicipramc Icicinxt50 ( (NEXT50IETF) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Icicipramc Icicinxt50 stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Icicipramc Icicinxt50 in short term and the buy signal is strong.
Icicipramc Icicinxt50 Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Icicipramc Icicinxt50 in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Icicipramc Icicinxt50 is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 70.02 and Icicipramc Icicinxt50 (NEXT50IETF) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Icicipramc Icicinxt50 (NEXT50IETF) stock. Volume based technical analysis of Icicipramc Icicinxt50 (NEXT50IETF) stock is negative.
Icicipramc Icicinxt50 Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Click here for Icicipramc Icicinxt50 charts
Click here for further forecast and predictions for tomorrow
COMMODITY Gainers BSE Gainers BSE Losers BSE Scanner CLOSED NEAR HIGH BSE Scanner CLOSED NEAR LOW USA Gainers USA Losers USA Scanner CLOSED NEAR HIGH USA Scanner CLOSED NEAR LOW USA Scanner UPTRENDING USA Scanner DOWNTRENDING
Munafa NEWSTerms of Use Stock Market News! © munafa.org2025 All Rights reserved.